Arvinas (ARVN) Stock Price, Quote, News & History | Benzinga

Arvinas Inc (ARVN) Stock Price, Quote, News & History

ARVNNASDAQ

Trade with Public

Trade with Public

$9.08

-0.34-3.61%

At close: May 15, 5:00 PM EST

$8.88

-0.20-2.20%

After Hours: May 15, 4:08 PM EST

Earnings: Q1 2026 Earnings were released on Tue May 12th, before the market open

Conference Call: The most recent conference call started at 8:00 AM, 5 days ago

Click to view the webcast

OverviewNews Earnings Options Analyst Ratings Insider Trades Short Interest Stock Report

Key Statistics

Open

$9.30

Close

$9.08

Volume / Avg.

968.10K / 900.88K

Day Range

$8.87 - $9.36

52 Wk Range

5.90 - 14.51

Market Cap

$570.31M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

30

Short Interest

8%

Days to Cover

7.27

Recent Arvinas Inc News

Rigel Pharmaceuticals Inks Breast Cancer Drug Deal With Arvinas, Pfizer

Rigel Pharmaceuticals stock jumps after signing a VEPPANU licensing deal with Arvinas and Pfizer following recent FDA approval.

Vandana Singh

Pfizer, Arvinas Win FDA Nod For First-Of-Its-Kind Breast Cancer Therapy

Pfizer and Arvinas secure FDA approval for VEPPANU (vepdegestrant), a first-of-its-kind treatment for ESR1-mutated advanced breast cancer.

Vandana Singh

Pfizer, Arvinas Partnered Breast Cancer Drug Cuts Progression Risk By 43% In Trial, Seeks FDA Approval

Arvinas and Pfizer submit NDA to FDA for vepdegestrant after Phase 3 data shows efficacy in ESR1-mutated ER+/HER2- breast cancer patients

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-254.10M

Investing Cash Flow (TTM)

351.80M

Financing Cash Flow (TTM)

-91.40M

Free Cash Flow (TTM)

-256.90M

Capital Expenditure (TTM)

-2.80M

Net Change in Cash (TTM)

6.30M

Analyst Trends and Forecast

1

Dec 25

1

Jan

2

1

Feb

3

Mar

3

May

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.7

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

-$20.00M

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

7.24

PB Ratio (TTM)

1.57

Earnings Yield % (TTM)

-33.78%

Earnings Yield % (FWD)

-36.43%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$6.00

Company Debt

Total Debt

$300.00K

LT Debt

$300.00K

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-$200.00K

Total Cash

$87.30M

Debt to Equity

0.02

Issuance of Debt (TTM)

-$200.00K

Repayment of Debt (TTM)

-$200.00K

Key Statistics

Open

$9.30

Close

$9.08

Volume / Avg.

968.10K / 900.88K

Day Range

$8.87 - $9.36

52 Wk Range

5.90 - 14.51

Market Cap

$570.31M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

30

Short Interest

8%

Days to Cover

7.27

About

Sector

Health Care

Industry

Pharmaceuticals

Arvinas Inc is a clinical-stage biotechnology company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development, and commercialization of therapies that degrade disease-cau...

Show More

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy Arvinas (ARVN) stock?

A

You can purchase shares of Arvinas (NASDAQ:ARVN) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Arvinas (ARVN) competitors?

A

There are no as such competitors for Arvinas.

Q

What is the forecast, or price target, for Arvinas (ARVN) stock?

A

Arvinas has a consensus price target of $22.81.

Q

What is the current price for Arvinas (ARVN)?

A

The stock price for Arvinas (NASDAQ: ARVN) is $8.88 last updated May 15, 2026 at 4:08 PM EDT.

Q

Does Arvinas (ARVN) pay a dividend?

A

There are no upcoming dividends for Arvinas.

Q

When is Arvinas (NASDAQ:ARVN) reporting earnings?

A

Arvinas does not have any upcoming earnings scheduled.

Q

Is Arvinas (ARVN) going to split?

A

There is no upcoming split for Arvinas.

Q

What sector and industry does Arvinas (ARVN) operate in?

A

Arvinas is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.